title: From Vaquez to Dameshek through JAK…2 much for polycythemia vera to be feared?
authors.affiliation: Hematology and Bone Marrow Transplantation Unit, San Gerardo Hospital, University of Milan Bicocca, Via Pergolesi 33, Monza, Italy. mcarpenedo@katamail.com
authors.forename: Monica
authors.initials: M
authors.lastname: Carpenedo
authors.forename: Enrico Maria
authors.initials: EM
authors.lastname: Pogliani
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D011087:Polycythemia Vera / Q000150:complications / Q000235:genetics*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D001241:Aspirin
references.citation: Lancet. 2005 Mar 19-25;365(9464):1054-61
references.pmid: 15781101
references.citation: Nature. 2005 Apr 28;434(7037):1144-8
references.pmid: 15793561
references.citation: N Engl J Med. 1974 Jun 13;290(24):1382
references.pmid: 4827655
references.citation: Curr Drug Targets. 2007 Feb;8(2):205-16
references.pmid: 17305499
references.citation: Cancer Cell. 2005 Apr;7(4):387-97
references.pmid: 15837627
references.citation: Intern Emerg Med. 2010 Oct;5(5):375-84
references.pmid: 20237866
references.citation: Hematology Am Soc Hematol Educ Program. 2008;:69-75
references.pmid: 19074061
references.citation: N Engl J Med. 2004 Jan 8;350(2):114-24
references.pmid: 14711910
references.citation: Intern Emerg Med. 2010 Oct;5(5):411-3
references.pmid: 20607450
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2224-32
references.pmid: 15710945
references.citation: Exp Hematol. 2007 Jun;35(6):931-8
references.pmid: 17533047
references.citation: Haematologica. 2003 Jan;88(1):13-8
references.pmid: 12551821
references.citation: Blood. 1951 Apr;6(4):372-5
references.pmid: 14820991
references.citation: N Engl J Med. 2005 Apr 28;352(17):1779-90
references.pmid: 15858187